Profound Medical Corp. (PROF): Price and Financial Metrics


Profound Medical Corp. (PROF): $14.62

0.18 (+1.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PROF POWR Grades


  • Growth is the dimension where PROF ranks best; there it ranks ahead of 48.01% of US stocks.
  • The strongest trend for PROF is in Value, which has been heading up over the past 47 weeks.
  • PROF ranks lowest in Quality; there it ranks in the 5th percentile.

PROF Stock Summary

  • PROF's went public 1.88 years ago, making it older than just 3.12% of listed US stocks we're tracking.
  • With a price/sales ratio of 48.8, Profound Medical Corp has a higher such ratio than 94.97% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.07 for Profound Medical Corp; that's greater than it is for just 6.32% of US stocks.
  • Stocks that are quantitatively similar to PROF, based on their financial statements, market capitalization, and price volatility, are ATNX, GPL, RDUS, CYRN, and AKBA.
  • Visit PROF's SEC page to see the company's official filings. To visit the company's web site, go to www.profoundmedical.com.

PROF Price Target

For more insight on analysts targets of PROF, see our PROF price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $26.60 Average Broker Recommendation 1.4 (Strong Buy)

PROF Stock Price Chart Interactive Chart >

Price chart for PROF

PROF Price/Volume Stats

Current price $14.62 52-week high $28.97
Prev. close $14.44 52-week low $13.43
Day low $14.19 Volume 32,500
Day high $14.79 Avg. volume 68,843
50-day MA $15.17 Dividend yield N/A
200-day MA $19.40 Market Cap 298.06M

Profound Medical Corp. (PROF) Company Bio


Profound Medical Corp. operates as a medical device company. The Company develops and commercializes technology for the treatment of localized prostate cancer. Profound Medical offers its services worldwide.


PROF Latest News Stream


Event/Time News Detail
Loading, please wait...

PROF Latest Social Stream


Loading social stream, please wait...

View Full PROF Social Stream

Latest PROF News From Around the Web

Below are the latest news stories about Profound Medical Corp that investors may wish to consider to help them evaluate PROF as an investment opportunity.

Profound Medical to Participate in September Virtual Investor Conferences

TORONTO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announce today that management will participate in two investor conferences in September. Lake Street’s 5th Annual Best Ideas Growth Conference: Profound is scheduled to participate in a series of one-on-one meetings on September 15, 20

Yahoo | September 8, 2021

We're Not Worried About Profound Medical's (TSE:PRN) Cash Burn

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Yahoo | August 19, 2021

Profound Medical Announces Second Quarter 2021 Financial Results

TORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the second quarter ended June 30, 2021. Recent Corporate Highlights On April 21, 2021, the Company participated in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference.On May 6, 2021, Pr

Yahoo | August 4, 2021

PROFOUND MEDICL (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

PROFOUND MEDICL (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 28, 2021

Profound Medical to Participate in A.G.P.’s Virtual MedTech Summer Conference

TORONTO, July 22, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021. The event will consist of one-on-one virtual investor meetings. Due to the format of the event, no webcast will be

Yahoo | July 22, 2021

Read More 'PROF' Stories Here

PROF Price Returns

1-mo -0.68%
3-mo -20.63%
6-mo -30.15%
1-year -13.95%
3-year 148.64%
5-year N/A
YTD -28.89%
2020 87.76%
2019 160.71%
2018 -35.64%
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8138 seconds.